The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Site maintenance Monday, July 8th, 2024. Please note that access to some content and account information will be unavailable on this date.
ArticleNo Access

Schizophrenia: A Review of Diagnostic and Biological Issues II. Biological Issues

Published Online:https://doi.org/10.1176/ps.34.5.423

Over the years schizophrenia has been the object of an extensive amount of research. In Part I of this paper, published in the April H& CP, the authors discussed research into diagnosis and prognosis. In particular, they outlined the studies that have been done on the major diagnostic systems, induding the first-rank symptoms, theflexible system, the New Haven Schizophrenia Index, the Feigbner criteria, the Research Diagnostic Criteria, and the Diagnostic and Statistical Manual of Mental Disorders, third edition. in Part ii they describe the literature on biological issues in schizophrenia. included in their survey are the studies on neuropathological Issues and on genetic and biological hypotheses of etiology and pathogenesis. in particular they discuss the possible roles ofdopamine, endorphins and neuropeptides, endogenous psychotomimetics, and viruses in schizophrenia.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.